{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:06:29Z","timestamp":1791648389532,"version":"4.3.4"},"reference-count":120,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011744","name":"National University Health System","doi-asserted-by":"publisher","award":["NCSP2.0\/2023\/NUHS\/DH"],"award-info":[{"award-number":["NCSP2.0\/2023\/NUHS\/DH"]}],"id":[{"id":"10.13039\/501100011744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001350","name":"Ministry of Health -Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-001370"],"award-info":[{"award-number":["MOH-001370"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["TA24jan-0010"],"award-info":[{"award-number":["TA24jan-0010"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.cgh.2024.09.037","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T12:04:01Z","timestamp":1734609841000},"page":"1695-1709.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Incidence of Hepatobiliary Malignancies in Primary Sclerosing Cholangitis: Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3695-9701","authenticated-orcid":false,"given":"Matheus","family":"Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luan C.V.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Al-Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Q.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2024.09.037_bib1","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMra1506330","article-title":"Primary sclerosing cholangitis","volume":"375","author":"Lazaridis","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2024.09.037_bib2","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.cgh.2013.02.016","article-title":"Primary sclerosing cholangitis: diagnosis, prognosis, and management","volume":"11","author":"Singh","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib3","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1093\/ibd\/izad276","article-title":"Incidence and prevalence of primary sclerosing cholangitis: a meta-analysis of population-based studies","volume":"30","author":"Cooper","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.09.037_bib4","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.09.037_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2024.09.037_bib6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL Clinical Practice Guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib7","first-page":"89","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2024.09.037_bib8","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2024.09.037_bib9","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2024.09.037_bib10","author":"Wells"},{"key":"10.1016\/j.cgh.2024.09.037_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.cgh.2024.09.037_bib12","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1177\/0962280219889080","article-title":"DEPRESsion Screening Data (DEPRESSD) Collaboration. Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis","volume":"29","author":"McGrath","year":"2020","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.cgh.2024.09.037_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.cgh.2024.09.037_bib14","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.cgh.2024.09.037_bib15","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1136\/bmj.315.7121.1533","article-title":"Meta-analysis: principles and procedures","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2024.09.037_bib16","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s10620-023-08260-1","article-title":"Primary sclerosing cholangitis limited to intrahepatic bile ducts has distinctly better prognosis","volume":"69","author":"Are","year":"2024","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2024.09.037_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12876-023-02759-7","article-title":"Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory data","volume":"23","author":"Hu","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cgh.2024.09.037_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/jcm13010079","article-title":"The role of immunoglobulin G4 in outcomes of primary sclerosing cholangitis","volume":"13","author":"Vujasinovic","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.cgh.2024.09.037_bib19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.5217\/ir.2022.00087","article-title":"Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India","volume":"21","author":"Singh","year":"2023","journal-title":"Intest Res"},{"key":"10.1016\/j.cgh.2024.09.037_bib20","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s12072-022-10356-1","article-title":"Melbourne Liver Group. Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study","volume":"16","author":"Tan","year":"2022","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2024.09.037_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2022.100595","article-title":"Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis","volume":"4","author":"Grigoriadis","year":"2022","journal-title":"JHEP Reports"},{"key":"10.1016\/j.cgh.2024.09.037_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/his.14677","article-title":"Novel histological scoring for predicting disease outcome in primary sclerosing cholangitis","volume":"81","author":"Sj\u00f6blom","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.cgh.2024.09.037_bib23","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.dld.2020.09.011","article-title":"Italian Group for the study of Inflammatory Bowel Disease IG-IBD. Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study","volume":"53","author":"Ribaldone","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2024.09.037_bib24","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1111\/liv.15008","article-title":"Racial differences in primary sclerosing cholangitis mortality is associated with community socioeconomic status","volume":"41","author":"Are","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2024.09.037_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ueg2.12204","article-title":"Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: a population-based cohort study","volume":"10","author":"Yu","year":"2022","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.cgh.2024.09.037_bib26","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","article-title":"Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age","volume":"159","author":"Trivedi","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.09.037_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.17992\/lbl.2019.09.245","article-title":"Primary sclerosing cholangitis in Iceland 1992-2012","volume":"105","author":"Gu\u00f0nason","year":"2019","journal-title":"Laeknabladid"},{"key":"10.1016\/j.cgh.2024.09.037_bib28","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/hep.30479","article-title":"Factors associated with outcomes of patients with primary sclerosing cholangitis and development and validation of a risk scoring system","volume":"69","author":"Goode","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2024.09.037_bib29","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/ecco-jcc\/jjz094","article-title":"Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: a multicentre retrospective cohort study","volume":"13","author":"Guerra","year":"2019","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.09.037_bib30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/apt.15146","article-title":"Longitudinal analysis of CA19-9 reveals individualised normal range and early changes before development of biliary tract cancer in patients with primary sclerosing cholangitis","volume":"49","author":"Wannhoff","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.09.037_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12664-019-00968-1","article-title":"Clinical profile and outcome of primary sclerosing cholangitis: a single-centre experience from western India","volume":"38","author":"Tibdewal","year":"2019","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.09.037_bib32","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/liv.13548","article-title":"Inflammatory bowel disease with primary sclerosing cholangitis: a Danish population-based cohort study 1977-2011","volume":"38","author":"S\u00f8rensen","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2024.09.037_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209352","article-title":"Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients","volume":"13","author":"Kumagai","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2024.09.037_bib34","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00384-018-3123-6","article-title":"Risk factors and clinical courses of concomitant primary sclerosing cholangitis and ulcerative colitis: a Korean multicenter study","volume":"33","author":"Park","year":"2018","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.cgh.2024.09.037_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MEG.0000000000000747","article-title":"Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up","volume":"29","author":"Fraga","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib36","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007116","article-title":"Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom","volume":"96","author":"Liang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2024.09.037_bib37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ajg.2016.55","article-title":"Duration of inflammatory bowel disease is associated with increased risk of cholangiocarcinoma in patients with primary sclerosing cholangitis and IBD","volume":"111","author":"Gulamhusein","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.09.037_bib38","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/MEG.0000000000000596","article-title":"Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options","volume":"28","author":"Franceschet","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib39","first-page":"43","article-title":"Comparison of outcomes for patients with primary sclerosing cholangitis associated with ulcerative colitis and Crohn\u2019s disease","volume":"4","author":"Navaneethan","year":"2016","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.cgh.2024.09.037_bib40","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/apt.13516","article-title":"Patients with large-duct primary sclerosing cholangitis and Crohn\u2019s disease have a better outcome than those with ulcerative colitis, or without IBD","volume":"43","author":"Fevery","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.09.037_bib41","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/liv.13328","article-title":"Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort","volume":"37","author":"Liu","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2024.09.037_bib42","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/MIB.0000000000000690","article-title":"Impact of concurrent non-IBD immunological diseases on the outcome of primary sclerosing cholangitis","volume":"22","author":"Jegadeesan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.09.037_bib43","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.cgh.2016.07.032","article-title":"No evidence that azathioprine increases risk of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"14","author":"Zenouzi","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib44","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/00365521.2014.946085","article-title":"Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease","volume":"50","author":"Manninen","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.09.037_bib45","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.crohns.2014.01.019","article-title":"Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease","volume":"8","author":"Ananthakrishnan","year":"2014","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.09.037_bib46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/ecco-jcc\/jju013","article-title":"Prognosis of primary sclerosing cholangitis in Israel is independent of coexisting inflammatory bowel disease","volume":"9","author":"Yanai","year":"2015","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.09.037_bib47","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.dld.2014.06.010","article-title":"The impact of elevated serum IgG4 levels in patients with primary sclerosing cholangitis","volume":"46","author":"Benito de Valle","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2024.09.037_bib48","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2024.09.037_bib49","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/MEG.0b013e3283554bbf","article-title":"Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience","volume":"24","author":"Chapman","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib50","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1478-3231.2011.02575.x","article-title":"Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term single-centre study","volume":"32","author":"Fevery","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2024.09.037_bib51","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/gut.2010.235408","article-title":"Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?","volume":"60","author":"Marelli","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.09.037_bib52","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.cgh.2011.08.027","article-title":"Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis","volume":"9","author":"Ngu","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib53","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/MEG.0b013e328331c2b7","article-title":"Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study","volume":"22","author":"Garioud","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib54","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib55","first-page":"312","article-title":"Primary sclerosing cholangitis in Turkish patients: characteristic features and prognosis","volume":"8","author":"Ataseven","year":"2009","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.cgh.2024.09.037_bib56","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000128169","article-title":"Cholangiocarcinoma complicating primary sclerosing cholangitis: a 24-year experience","volume":"25","author":"Morris-Stiff","year":"2008","journal-title":"Dig Surg"},{"key":"10.1016\/j.cgh.2024.09.037_bib57","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1478-3231.2008.01726.x","article-title":"Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis","volume":"28","author":"Tanaka","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2024.09.037_bib58","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/gut.51.5.731","article-title":"Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis","volume":"51","author":"Bj\u00f6rnsson","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.09.037_bib59","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/gut.51.4.562","article-title":"Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population","volume":"51","author":"Ponsioen","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.09.037_bib60","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0168-8278(02)00036-3","article-title":"Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC)","volume":"36","author":"Broom\u00e9","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib61","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.09.037_bib62","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","article-title":"Small-duct primary sclerosing cholangitis: a long-term follow-up study","volume":"35","author":"Angulo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2024.09.037_bib63","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","article-title":"Natural history and prognostic variables in primary sclerosing cholangitis","volume":"100","author":"Farrant","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.09.037_bib64","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/0016-5085(87)90618-4","article-title":"Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients","volume":"92","author":"Helzberg","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.09.037_bib65","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/hep.29730","article-title":"Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis","volume":"67","author":"Ali","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2024.09.037_bib66","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41575-022-00690-y","article-title":"The microbiota and the gut-liver axis in primary sclerosing cholangitis","volume":"20","author":"Hov","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib67","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1111\/liv.15339","article-title":"Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"42","author":"Zhang","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2024.09.037_bib68","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/s12276-023-01042-9","article-title":"Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis","volume":"55","author":"Kim","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.cgh.2024.09.037_bib69","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27598","article-title":"The clinical course of cirrhosis: the importance of multistate models and competing risks analysis","volume":"62","author":"Jepsen","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2024.09.037_bib70","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s10620-023-08260-1","article-title":"Primary sclerosing cholangitis limited to intrahepatic bile ducts has distinctly better prognosis","volume":"69","author":"Are","year":"2024","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2024.09.037_bib71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12876-023-02759-7","article-title":"Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory data","volume":"23","author":"Hu","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cgh.2024.09.037_bib72","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/jcm13010079","article-title":"The role of immunoglobulin G4 in outcomes of primary sclerosing cholangitis","volume":"13","author":"Vujasinovic","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.cgh.2024.09.037_bib73","doi-asserted-by":"crossref","first-page":"452","DOI":"10.5217\/ir.2022.00087","article-title":"Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India","volume":"21","author":"Singh","year":"2023","journal-title":"Intest Res"},{"key":"10.1016\/j.cgh.2024.09.037_bib74","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s12072-022-10356-1","article-title":"Melbourne Liver Group. Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study","volume":"16","author":"Tan","year":"2022","journal-title":"Hepatology Int"},{"key":"10.1016\/j.cgh.2024.09.037_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2022.100595","article-title":"Development of a prognostic MRCP-score (DiStrict) for individuals with large-duct primary sclerosing cholangitis","volume":"4","author":"Grigoriadis","year":"2022","journal-title":"JHEP Reports"},{"key":"10.1016\/j.cgh.2024.09.037_bib76","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/his.14677","article-title":"Novel histological scoring for predicting disease outcome in primary sclerosing cholangitis","volume":"81","author":"Sj\u00f6blom","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.cgh.2024.09.037_bib77","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.dld.2020.09.011","article-title":"Italian Group for the study of Inflammatory Bowel Disease IG-IBD. Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study","volume":"53","author":"Ribaldone","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2024.09.037_bib78","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1111\/liv.15008","article-title":"Racial differences in primary sclerosing cholangitis mortality is associated with community socioeconomic status","volume":"41","author":"Are","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2024.09.037_bib79","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ueg2.12204","article-title":"Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: a population-based cohort study","volume":"10","author":"Yu","year":"2022","journal-title":"United European Gastroenterology J"},{"key":"10.1016\/j.cgh.2024.09.037_bib80","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","article-title":"Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age","volume":"159","author":"Trivedi","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.09.037_bib81","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/hep.30479","article-title":"Factors associated with outcomes of patients with primary sclerosing cholangitis and development and validation of a risk scoring system","volume":"69","author":"Goode","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2024.09.037_bib82","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/ecco-jcc\/jjz094","article-title":"Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: a multicentre retrospective cohort study","volume":"13","author":"Guerra","year":"2019","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.09.037_bib83","doi-asserted-by":"crossref","first-page":"371","DOI":"10.17992\/lbl.2019.09.245","article-title":"Primary sclerosing cholangitis in Iceland 1992-2012","volume":"105","author":"Gu\u00f0nason","year":"2019","journal-title":"Laeknabladid"},{"key":"10.1016\/j.cgh.2024.09.037_bib84","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/apt.15146","article-title":"Longitudinal analysis of CA19-9 reveals individualised normal range and early changes before development of biliary tract cancer in patients with primary sclerosing cholangitis","volume":"49","author":"Wannhoff","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.09.037_bib85","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12664-019-00968-1","article-title":"Clinical profile and outcome of primary sclerosing cholangitis: a single-centre experience from western India","volume":"38","author":"Tibdewal","year":"2019","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.09.037_bib86","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/liv.13548","article-title":"Inflammatory bowel disease with primary sclerosing cholangitis: a Danish population-based cohort study 1977-2011","volume":"38","author":"S\u00f8rensen","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2024.09.037_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209352","article-title":"Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients","volume":"13","author":"Kumagai","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2024.09.037_bib88","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00384-018-3123-6","article-title":"Risk factors and clinical courses of concomitant primary sclerosing cholangitis and ulcerative colitis: a Korean multicenter study","volume":"33","author":"Park","year":"2018","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.cgh.2024.09.037_bib89","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MEG.0000000000000747","article-title":"Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up","volume":"29","author":"Fraga","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib90","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weism\u00fcller","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.09.037_bib91","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007116","article-title":"Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom","volume":"96","author":"Liang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2024.09.037_bib92","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ajg.2016.55","article-title":"Duration of inflammatory bowel disease is associated with increased risk of cholangiocarcinoma in patients with primary sclerosing cholangitis and IBD","volume":"111","author":"Gulamhusein","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.09.037_bib93","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/MEG.0000000000000596","article-title":"Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options","volume":"28","author":"Franceschet","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib94","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/gastro\/gov007","article-title":"Comparison of outcomes for patients with primary sclerosing cholangitis associated with ulcerative colitis and Crohn\u2019s disease","volume":"4","author":"Navaneethan","year":"2016","journal-title":"Gastroenterol Rep"},{"key":"10.1016\/j.cgh.2024.09.037_bib95","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/apt.13516","article-title":"Patients with large-duct primary sclerosing cholangitis and Crohn\u2019s disease have a better outcome than those with ulcerative colitis, or without IBD","volume":"43","author":"Fevery","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2024.09.037_bib96","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/liv.13328","article-title":"Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort","volume":"37","author":"Liu","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2024.09.037_bib97","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/MIB.0000000000000690","article-title":"Impact of concurrent non-IBD immunological diseases on the outcome of primary sclerosing cholangitis","volume":"22","author":"Jegadeesan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2024.09.037_bib98","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.cgh.2016.07.032","article-title":"No evidence that azathioprine increases risk of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"14","author":"Zenouzi","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib99","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/00365521.2014.946085","article-title":"Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease","volume":"50","author":"Manninen","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2024.09.037_bib100","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.crohns.2014.01.019","article-title":"Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease","volume":"8","author":"Ananthakrishnan","year":"2014","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.09.037_bib101","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/ecco-jcc\/jju013","article-title":"Prognosis of primary sclerosing cholangitis in Israel is independent of coexisting inflammatory bowel disease","volume":"9","author":"Yanai","year":"2015","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.cgh.2024.09.037_bib102","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.dld.2014.06.010","article-title":"The impact of elevated serum IgG4 levels in patients with primary sclerosing cholangitis","volume":"46","author":"Benito de Valle","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2024.09.037_bib103","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2024.09.037_bib104","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/MEG.0b013e3283554bbf","article-title":"Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience","volume":"24","author":"Chapman","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib105","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/gut.2010.235408","article-title":"Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?","volume":"60","author":"Marelli","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.09.037_bib106","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.cgh.2011.08.027","article-title":"Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis","volume":"9","author":"Ngu","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib107","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/MEG.0b013e328331c2b7","article-title":"Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study","volume":"22","author":"Garioud","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib108","first-page":"312","article-title":"Primary sclerosing cholangitis in Turkish patients: characteristic features and prognosis","volume":"8","author":"Ataseven","year":"2009","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.cgh.2024.09.037_bib109","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib110","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000128169","article-title":"Cholangiocarcinoma complicating primary sclerosing cholangitis: a 24-year experience","volume":"25","author":"Morris-Stiff","year":"2008","journal-title":"Dig Surg"},{"key":"10.1016\/j.cgh.2024.09.037_bib111","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1478-3231.2008.01726.x","article-title":"Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis","volume":"28","author":"Tanaka","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2024.09.037_bib112","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/gut.51.5.731","article-title":"Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis","volume":"51","author":"Bj\u00f6rnsson","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.09.037_bib113","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/gut.51.4.562","article-title":"Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population","volume":"51","author":"Ponsioen","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.09.037_bib114","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0168-8278(02)00036-3","article-title":"Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC)","volume":"36","author":"Broom\u00e9","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2024.09.037_bib115","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","article-title":"Small-duct primary sclerosing cholangitis: a long-term follow-up study","volume":"35","author":"Angulo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2024.09.037_bib116","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.09.037_bib117","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","article-title":"Natural history and prognostic variables in primary sclerosing cholangitis","volume":"100","author":"Farrant","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.09.037_bib118","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/0016-5085(87)90618-4","article-title":"Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients","volume":"92","author":"Helzberg","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.09.037_bib119","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1478-3231.2011.02575.x","article-title":"Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term single-centre study","volume":"32","author":"Fevery","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2024.09.037_bib120","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/liv.14326","article-title":"Risk of gallbladder cancer in patients with primary sclerosing cholangitis and radiographically detected gallbladder polyps","volume":"40","author":"van Erp","year":"2020","journal-title":"Liver Int"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524010437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524010437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:24:47Z","timestamp":1783034687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356524010437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":120,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1542356524010437"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2024.09.037","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of Hepatobiliary Malignancies in Primary Sclerosing Cholangitis: Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2024.09.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the AGA Institute","name":"copyright","label":"Copyright"}]}}